Can Ocaliva Cause Liver Damage?

Obeticholic acid, known as Ocaliva, is a prescription medication. It is prescribed to some adults with primary biliary cholangitis. It was approved through the FDA’s accelerated approval program.

This approval relied on improvement in a liver test. This test is known as alkaline phosphatase (ALP). The focus was on improving ALP levels to support the approval process.

It was prescribed to patients who didn’t respond well to ursodeoxycholic acid.

Ocaliva and Obeticholic Acid

Ocaliva and obeticholic acid refer to the same drug. If you encounter either of these names in a prescription, on a label, or in a medical chart, it is the same drug. It may be helpful to have both names if it’s necessary to check records or talk to a doctor or attorney.

Research published in the New England Journal of Medicine shows that obeticholic acid improved a surrogate endpoint at a lower dose. It also targets different mechanisms. This is unlike ursodiol, which is the usual treatment for PBC.

Ocaliva Use for Primary Biliary Cholangitis

Ocaliva was used to treat PBC in patients who could not tolerate or did not respond well enough to ursodeoxycholic acid. The first trial for Ocaliva was on liver tests and not long-term effects. 

According to the New England Journal of Medicine, the trial only lasted two years. So, it did not prove long-term clinical outcomes.

Ocaliva operates on the bile acid pathways in the liver. Liver function may be low in patients at the time of the use of this drug. This may increase the likelihood of serious side effects.

Ocaliva Dosing, Liver Function and Safety Risks

Dosing errors and liver dysfunction have been cited in warnings from the FDA. An Australian Prescriberreported that obeticholic acid can worsen cholangitis. It may also result in increased jaundice and ascites.

Some risks increased with higher doses. They were greatest at the 10 mg/day limit, which was the maximum recommended dose.

Why Liver Test Monitoring Matters

Regular liver testing was recommended for patients on Ocaliva. Clinicians closely monitored patients and stopped use of the drug if needed. This may have helped reverse adverse changes in liver function.

This may help detect serious liver damage.

The following symptoms are warning signs. They are not evidence of your injury being caused by Ocaliva. However, they should prompt a visit to your doctor.

Jaundice or Yellowing Skin and Eyes

Yellow skin or eyes can be a sign of an impaired liver’s ability to process bilirubin. This is a serious symptom that should be reported to a doctor immediately.

Severe or Worsening Itching

PBC patients often suffer from itching. An acute or marked worsening of the itching, however, could indicate liver damage instead of the disease.

Abdominal Pain or Swelling

Abdominal pain, swelling, or pressure can show that liver function is getting worse. It could also indicate hepatic decompensation. All of this should not be overlooked, particularly in patients who were on Ocaliva.

Dark Urine, Pale Stools or Black Stools

Blood in urine, pale stools, black stools, bloody stools, or blood vomiting are serious warning signs. They may indicate liver problems.

New or Worsening Fatigue and Weakness

Tiredness, weakness, loss of appetite, or loss of weight should be treated seriously if they get worse or are new symptoms. These symptoms may indicate worsening liver function.

Confusion, Sleepiness or Mental Status Changes

Severe liver impairment may cause toxins to build up in the blood and affect the brain, leading to confusion. It can lead to mood swings. There may be slurred speech and drowsiness.

Some individuals may experience difficulty getting up. The Cleveland Clinic stated that hepatic encephalopathy can change a person’s personality. It can also impair mental acuity and awareness.

In severe cases, it can lead to alterations of mental status and other complications.

Vomiting Blood or Gastrointestinal Bleeding

Vomiting blood, coughing blood, black stools, or any sign of GI bleeding should be treated as an emergency. The Mayo Clinic lists acute liver failure as a medical emergency. Liver function can deteriorate rapidly on a day-to-day basis, often within days or weeks.

There are some symptoms of the liver that need immediate attention. If you suffer from any of the following, do not delay.

Symptoms That May Require Immediate Medical Care

The following symptoms could be a warning sign for serious liver conditions and should not be dismissed.

• Rapid change in the color of skin or of the eyes (jaundice)
• Struggling to focus, feeling lost or confused, or having sleep issues.
• Blood in vomit or black, sticky stools
• Sudden abdominal pain or sudden increase in the size of the abdomen
• Loss of strength or function (or weakness) in the body all at once

The Cleveland Clinic states that acute liver failure is a serious condition. It can be life-threatening. It may result in complications of the liver affecting other organs and causing death. This may occur quickly, even in people whose livers are not diseased.

When to Contact a Liver Specialist

Speak with your hepatologist or your doctor if you notice any of the following symptoms. Do this prior to starting Ocaliva, escalation, or maintenance. A prompt, appropriate response may improve recovery potential. It’s also useful to keep medical records for future litigation.

PBC is a chronic progressive liver disease that can worsen over time. This can make it difficult to determine whether this liver damage is caused by Ocaliva. So, laboratory testing, medical records, and time are very important.

Timing of Symptoms After Starting Ocaliva

This could be important if you have symptoms or if symptoms worsen as soon as you begin using Ocaliva. This includes dosage intensity and length of treatment. A detailed timeline can help distinguish disease progression from a drug injury.

Liver Test Changes After Ocaliva Use

Laboratory tests used to track liver function include MELD, INR, bilirubin, ALP, and AST. They help show whether liver function is normal or not. They are used to assess the response to treatment in individuals undergoing therapy. Pre-, during, and post-usage measurements can be compared to identify any trend.

Symptom Patterns That May Suggest Serious Liver Injury

If a person exhibits some symptoms, the liver may be damaged. An appropriate medical response is required. There are certain symptoms that could indicate the problem. 

Keep an eye out for jaundice, dark urine, or abdominal swelling. Confusion, weakness, and gastrointestinal bleeding are other severe symptoms. These symptoms can be a sign of more advanced liver changes than what is expected to worsen with PBC.

Why Medical Records Are Needed to Review Causation

Records are essential for an attorney and a doctor to see if Ocaliva caused or contributed to liver injury. The use of the drug, dosage of the drug, symptoms, diagnoses, etc. are all important. However, when conducting a review, other causes must be considered.

The FDA has issued multiple Ocaliva safety communications over the years. The warnings told prescribers about the risks of Ocaliva.

2017 FDA Warning About Serious Liver Injury and Dosing Errors

The FDA cautioned about severe liver damage and fatality resulting from the misuse of the medicine. It can be particularly dangerous for individuals who have liver issues. This early warning alerted prescribers to the serious risks associated with Ocaliva in some patients.

2018 Ocaliva Boxed Warning

The boxed warning is the strictest warning listed on the FDA label for Ocaliva. The boxed warning indicates a serious or life-threatening risk with the drug.

2021 FDA Restriction for Advanced Cirrhosis

In 2021, the FDA restricted Ocaliva in PBC patients with advanced cirrhosis. This was after serious liver injury, liver transplant, and death were reported in that group. The FDA reported severe liver damage in people with cirrhosis. They later expanded this to include those without cirrhosis.

2024 FDA Warning for Patients Without Cirrhosis

In 2024, the FDA’s worries were not just confined to those suffering from cirrhosis. The agency warned that non-cirrhotic patients might face liver injury. They also cited an increase in liver transplants and mortality. The risks were higher for people taking this drug than for those taking a placebo.

2025 Ocaliva Market Withdrawal

As of November 14, 2025, Ocaliva has been withdrawn from the U.S. market. The FDA asked Intercept to withdraw Ocaliva. Ocaliva’s post-marketing trial did not verify clinical benefit. The FDA reported more early-stage patients got liver transplants. This happened when they took Ocaliva. They also died more often than those who were given a placebo.

Boxed warnings are the strongest labels from the FDA. They show serious risks for a product. The medicine may cause serious or life-threatening harm. It is very important to inform patients and doctors of this risk prior to use.

Why Ocaliva Received a Boxed Warning

The boxed warning for Ocaliva highlights liver injury reports. Some cases have even led to liver failure in patients using the drug. Many harms came from dosing errors. 

Patients with liver problems received doses meant for those with normal liver function. As they took the drug, it built up to toxic levels in their bodies. The FDA later limited Ocaliva. It was restricted in patients with advanced cirrhosis. 

While the drug was available, regular liver testing was recommended to help detect problems early.

Liver Failure, Liver Transplant and Death Risks

Serious adverse effects have been reported in some users of Ocaliva. These may result in liver failure, liver transplant, or death. These are not risks in every patient, but are so serious they merit the highest FDA warning.

As of November 2025, Ocaliva is no longer available in the U.S. market. The withdrawal followed safety concerns and failure to verify clinical benefit. It followed unfavorable results from post-marketing research.

FDA Request for Ocaliva Withdrawal

The FDA looked at postmarket clinical data. They found issues with liver injury, transplant, death, and a poor benefit-risk ratio. The Agency asked Intercept to remove the drug.

Intercept’s Voluntary Withdrawal of Ocaliva

In 2025, Intercept agreed to pull Ocaliva from the U.S. market. The decision came after the FDA found an unfavorable benefit-risk profile. This decision affects many Americans.

What the Ocaliva Withdrawal Means for Patients

If using Ocaliva, discuss other treatment options with your doctor. If there was considerable damage to your liver during treatment with the medication, the withdrawal may be connected to a lawsuit review.

There are several pieces of evidence that link Ocaliva to liver damage. These include, but are not limited to, FDA communications. They are also based on postmarket trial data, case studies, and published research.

FDA Postmarket Clinical Trial Review

The FDA analyzed the data from the postmarketing period. Significant liver injury problems arose. The review contributed to further restrictions and the drug’s eventual withdrawal.

Liver Transplant and Death Data

Key findings from the postmarket data on the FDA were revealed. More liver transplants were performed in patients who were taking Ocaliva. They also had higher death rates compared to those on placebo.

Seven of 81 patients (9%) receiving Ocaliva underwent liver transplant. In contrast, only 1 out of 68 patients who took a placebo needed one. The number of patients who died on Ocaliva (4) was four times higher than that of placebo (1).

Post-Restriction Liver Injury Reports

After the 2021 restriction, the FDA found more reports of serious liver outcomes in patients taking Ocaliva. These comprised liver transplant, transplant assessment or listing, and liver-related death. 

The agency frequently stated that it was unable to assess the suitability of the use of Ocaliva. This has been due to a lack of information being available.

Attention is placed on medical care. If this occurs, gather all documents in this case. In addition, be sure to get a legal review. This may help preserve your options.

Talk to Your Doctor Before Changing Medication

Do not use or alter any medications without medical advice. If you are taking a prescription drug, consult the prescribing physician. This is essential if you’re concerned about how well your liver is working.

Ask About Liver Function Testing

Obtain liver function tests if required by consulting with your doctor. This can show whether there is any change in liver function. It is important to know if the use of Ocaliva may have impacted your liver.

Save Your Ocaliva Prescription Records

Collect all Ocaliva records. This includes information on pill bottles, pharmacy printouts, and refill history. Also, keep dosage information.

Track Your Symptoms and Diagnosis Timeline

Document Ocaliva introduction, dosage changes, times of symptom onset, hospitalizations, diagnosis, and interventions. A helpful tool that you can provide for a legal review is a good timeline.

If you used Ocaliva and then suffered from severe liver damage, it may be worth considering a legal review. There are certain types of injuries that can form the basis of a claim, although every case is different.

When Liver Damage After Ocaliva May Lead to Legal Review

Patients who had taken Ocaliva might also encounter a serious liver problem in the future. These issues can range from liver damage to cirrhosis or liver failure. If you experienced any of the above, it may be time for a legal review.

Alleged Failure to Warn About Liver Injury Risks

Some lawsuits may allege that patients and doctors were inadequately warned about liver risks associated with Ocaliva. In addition, plaintiffs may allege that warnings were issued too late.

Ocaliva Lawsuit Claims Against Intercept Pharmaceuticals

Claims can include:

• Defective warnings
• Delayed safety updates
• Unsafe product promotions
• Other product liability issues
• The specific claims in any case depend on the individual facts.

Why FDA Warnings May Matter in an Ocaliva Claim

An FDA warning could help inform arguments regarding when and what Intercept knew. They do not create a cause for a given situation, but can be helpful for a legal review.

This varies from person to person. Typical factors taken into consideration during a case review include:

Clear documentation will assist with the identification of Ocaliva use time. It will provide a description of the injury, its severity, and whether there are other factors that may have contributed to the injury. The following records are important to collect:

• Prescription use details (e.g., records of prescription Ocaliva or obeticholic acid use, refill date history, directions for use)
• Liver function tests before, during, and after the time of Ocaliva treatment
• Keep records pertaining to hepatology notes, imaging, diagnosis codes, cirrhosis, and liver injury.
• Hospital, emergency room, transplant evaluation, or transplant surgery records
• A copy of the death certificate/autopsy report (if applicable)

Prescription and Pharmacy Records

Collect Ocaliva prescriptions. Record the refill date for each. Record dosage instructions. In addition, look for any documents that refer to the drug’s chemical name, obeticholic acid (OBA).

Liver Function Test Results

Results obtained prior to, around the time of, and after Ocaliva use are significant. These may include ALT, AST, ALP, bilirubin, INR, and MELD.

Cirrhosis or Liver Injury Diagnosis Records

The time and manner in which liver damage was diagnosed via hepatology notes, imaging results, diagnosis codes, and specialist liver records will help to demonstrate this. 

According to Mayo Clinic, liver damage caused by cirrhosis is permanent, meaning that if the liver becomes damaged, it may have long-term effects on a person’s health.

Hospitalization or Emergency Care Records

The ER records may document the seriousness of the injuries. Information about treatments is available in admission notes. Discharge summaries give an overview of the treatment provided when they leave the hospital. The steps that have been taken to recover are recorded in treatment records.

Transplant Evaluation or Surgery Records

If you were evaluated for or received a liver transplant, obtain those records. In addition, keep any medical documentation from the transplant and/or follow-up appointments.

Death Certificate or Autopsy Records

Liver issues may be documented on a death certificate or autopsy, including liver failure, cirrhosis, or GI bleeding. This information can help with wrongful death reviews.

Compensation is dependent on the instances of every situation. There is no definite way of determining the outcome, but in severe injury situations, the types of damages that can be awarded are described below.

Medical Bills and Future Care

This can include:

• Hospitalization
• Specialist appointments
• Ongoing care
• Medication
• Costs for continuing treatment of liver damage

Lost Income and Reduced Earning Capacity

The non-attendance, work capacity, disability, and impact of caring can all be taken into account.

Liver Transplant and Long-Term Treatment Costs

There are numerous long-term expenses associated with transplant surgery. The post-transplant care and maintenance of the immunities must be paid for. The costs and logistical difficulties of travel also can come at a high price. The total cost of these can add up over the years.

Wrongful Death Damages

Eligible family members may be entitled to compensation for funeral expenses. Additionally, they can recover for lost wages and other losses that may have occurred because of the loved one’s death, if the state law permits.

You or a family member may have a legal claim. This applies if you had a serious liver injury, cirrhosis, or liver failure. It also includes cases where you needed a liver transplant after taking Ocaliva or obeticholic acid. 

Contact Winder Law Firm today to request a case review. There is no guarantee of eligibility or results.

Call for a free consultation about a potential Ocaliva injury lawsuit.